DNA Methylation as a Biomarker in Nasopharyngeal Carcinoma
Authors:
Open Access
- 1 January 2014
- book chapter
- Published by Springer Nature
- p. 1-18
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Patterns of aberrant DNA hypermethylation in nasopharyngeal carcinoma in Tunisian patientsClinica Chimica Acta, 2012
- Role of EBNA1 in NPC tumourigenesisSeminars in Cancer Biology, 2012
- Familial and large-scale case–control studies identify genes associated with nasopharyngeal carcinomaSeminars in Cancer Biology, 2012
- TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinomaBMC Cancer, 2010
- Traditional Cantonese diet and nasopharyngeal carcinoma risk: a large-scale case-control study in Guangdong, ChinaBMC Cancer, 2010
- Putative tumour-suppressor gene DAB2is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinomaBMC Cancer, 2010
- Involvement of a cell adhesion molecule, TSLC1/IGSF4, in human oncogenesisCancer Science, 2005
- Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancersOncogene, 2003
- Rho GTPases in cell biologyNature, 2002
- DAP-kinase Participates in TNF-alpha and Fas-induced Apoptosis and Its Function Requires the Death DomainJournal of Cell Biology, 1999